A new standard of care for patients with high-risk rhabdomyosarcoma? - Authors' reply

Gianni Bisogno, Andrea Ferrari, Soledad Gallego Melcon, Gian Luca De Salvo, Christophe Bergeron, Meriel Jenney

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)e3
Number of pages1
JournalThe Lancet. Oncology
Volume21
Issue number1
DOIs
Publication statusPublished - Jan 2020

Keywords

  • Cyclophosphamide
  • Humans
  • Maintenance Chemotherapy
  • Rhabdomyosarcoma
  • Standard of Care
  • Vinorelbine

Cite this